BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 2555137)

  • 1. Solubilization of high affinity corticotropin-releasing factor receptors from rat brain: characterization of an active digitonin-solubilized receptor complex.
    Grigoriadis DE; Zaczek R; Pearsall DM; De Souza EB
    Endocrinology; 1989 Dec; 125(6):3068-77. PubMed ID: 2555137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticotropin-releasing factor receptors in mouse spleen: identification, autoradiographic localization, and regulation by divalent cations and guanine nucleotides.
    Webster EL; De Souza EB
    Endocrinology; 1988 Feb; 122(2):609-17. PubMed ID: 2828007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solubilization of high affinity peptide-YY receptors from porcine brain.
    Inui A; Okita M; Miura M; Hirosue Y; Nakajima M; Shii K; Baba S; Balasubramaniam A; Kasuga M
    Endocrinology; 1992 Apr; 130(4):2120-8. PubMed ID: 1312444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The brain corticotropin-releasing factor (CRF) receptor is of lower apparent molecular weight than the CRF receptor in anterior pituitary. Evidence from chemical cross-linking studies.
    Grigoriadis DE; De Souza EB
    J Biol Chem; 1988 Aug; 263(22):10927-31. PubMed ID: 2839512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticotropin-releasing factor (CRF) receptors in intermediate lobe of the pituitary: biochemical characterization and autoradiographic localization.
    Grigoriadis DE; De Souza EB
    Peptides; 1989; 10(1):179-88. PubMed ID: 2546128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticotropin-releasing factor receptors in human small cell lung carcinoma cells: radioligand binding, second messenger, and northern blot analysis data.
    Dieterich KD; Grigoriadis DE; De Souza EB
    Endocrinology; 1994 Oct; 135(4):1551-8. PubMed ID: 7925116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of corticotropin-releasing factor receptor-mediated adenylate cyclase activity in the rat central nervous system.
    Battaglia G; Webster EL; De Souza EB
    Synapse; 1987; 1(6):572-81. PubMed ID: 2843998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solubilization and purification of melatonin receptors from lizard brain.
    Rivkees SA; Conron RW; Reppert SM
    Endocrinology; 1990 Sep; 127(3):1206-14. PubMed ID: 2167210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.
    Grigoriadis DE; Liu XJ; Vaughn J; Palmer SF; True CD; Vale WW; Ling N; De Souza EB
    Mol Pharmacol; 1996 Sep; 50(3):679-86. PubMed ID: 8794910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional corticotropin-releasing factor (CRF) receptors in mouse spleen: evidence from adenylate cyclase studies.
    Webster EL; Battaglia G; De Souza EB
    Peptides; 1989; 10(2):395-401. PubMed ID: 2547206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solubilization and characterization of a guanine nucleotide-sensitive form of the calcitonin gene-related peptide receptor.
    Chatterjee TK; Moy JA; Cai JJ; Lee HC; Fisher RA
    Mol Pharmacol; 1993 Feb; 43(2):167-75. PubMed ID: 8381507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticotropin-releasing factor receptors in the rat central nervous system: characterization and regional distribution.
    De Souza EB
    J Neurosci; 1987 Jan; 7(1):88-100. PubMed ID: 3027279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solubilization of receptors for thyrotropin-releasing hormone from GH4C1 rat pituitary cells: demonstration of guanyl nucleotide sensitivity.
    Sullivan NJ; Lautens LL; Tashjian AH
    Mol Endocrinol; 1987 Dec; 1(12):889-98. PubMed ID: 2856405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of corticotropin-releasing factor receptors in dissociated brain cell cultures.
    Kapcala LP; De Souza EB
    Brain Res; 1988 Jul; 456(1):159-67. PubMed ID: 2842000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-[(3-cholamidopropyl)dimethylammonio]-1-propane sulfonate-solubilized binding sites for 2-[125I]iodomelatonin in chick brain retain sensitivity to guanine nucleotides.
    Ying SW; Niles LP
    J Neurochem; 1991 Feb; 56(2):580-6. PubMed ID: 1846401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and solubilization of vasoactive intestinal peptide receptors from rat lung membranes.
    Provow S; Veliçelebi G
    Endocrinology; 1987 Jun; 120(6):2442-52. PubMed ID: 3032591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and function of the ovine type 1 corticotropin releasing factor receptor (CRF1) and a carboxyl-terminal variant.
    Myers DA; Trinh JV; Myers TR
    Mol Cell Endocrinol; 1998 Sep; 144(1-2):21-35. PubMed ID: 9863624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solubilization of a guanine nucleotide-sensitive form of the P2Y-purinergic receptor.
    Jeffs RA; Cooper CL; Harden TK
    Mol Pharmacol; 1991 Jul; 40(1):85-92. PubMed ID: 1906978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticotropin-releasing factor binding to the anterior pituitary receptor is modulated by divalent cations and guanyl nucleotides.
    Perrin MH; Haas Y; Rivier JE; Vale WW
    Endocrinology; 1986 Mar; 118(3):1171-9. PubMed ID: 3004898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monkey corticotropin-releasing factor1 receptor: Complementary DNA cloning and pharmacological characterization.
    Oshida Y; Ikeda Y; Chaki S; Okuyama S
    Life Sci; 2004 Feb; 74(15):1911-24. PubMed ID: 14761672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.